Abstract. Primary B-cell lymphomas of the skin are defined as malignant B-cell proliferations pre senting with cutaneous involvement alone and no evidence of extracutaneous manifestations over a period of at least six months when complete staging has been performed. The major subtypes are fol licle center-cell lymphoma, marginal zone lymphoma and large B-cell lymphoma of the leg (EORTC classification 1997). Primary B-cell lymphomas of the skin differ significantly from nodal lymphomas especially with respect to their clinical behavior. Pseudolymphomas of the skin are inflammatory dis eases that simulate malignant lymphomas either clinically, histopathologically, or both. Particular 
Studies on malignant lymphoproliferative disorders of the skin have especially concerned lymphomas of the T-cell type. In recent years great attention has been also accorded to the group of primary cutaneous B-cell lymphomas, which occur far more frequently than gen erally believed.1-3 Patients with primary cutaneous B cell lymphomas can be divided into 2 groups: primary cutaneous B-cell lymphomas reveal cutaneous disease alone with no evidence of extracutaneous manifesta tions over a period of at least 6 months when a com plete staging examination has been performed. Patients with secondary cutaneous B-cell lymphomas show ex tracutaneous disease and subsequent development of skin lesions. The European Organization for Research and Treatment of Cancer (EORTC)-Cutaneous Lym phoma Project Group proposed a new classification for primary cutaneous lymphomas in 1997. 4 The most common types of primary cutaneous B-cell lymphomas are cutaneous follicle center-cell lymphoma, cutaneous marginal zone B-cell lymphoma, and large B-cell lym phoma of the leg. It is extremely important to empha size that primary cutaneous B-cell lymphomas differ significantly from their nodal counterparts revealing in most patients an excellent prognosis. Awareness of these special prognostic aspects ( Fig. 1) should prevent unnecessarily aggressive treatment schemes.
Follicle Center-cell Lymphoma Primary cutaneous follicle center-cell lymphoma is a relatively common cutaneous B-cell lymphoma, char acterized by the neoplastic proliferation of centrocytes and centroblasts confined to the skin.5
To this group belong most of the patients diagnosed in the past as "reticulohistiocytoma of the dorsum" or "Crosti's lymphoma" , typically located on the back.
The prognosis of patients with cutaneous follicle center cell lymphoma is favorable (survival rate 94%) (Fig.  IA) . Clinically solitary or grouped reddish-brown to reddish-blue papules, plaques or tumors surrounded by erythematous patches can be seen. Preferential loca tions are the head (scalp, forehead) and the back. Re currences are observed in about 50% of the cases, but dissemination to internal organs is rare. Histopathologically, follicle center-cell lymphoma is usually characterized by a diffuse growth pattern with proliferation of neoplastic centrocytes and centro blasts. A typical follicular pattern, however, is ob served in a distinct proportion of patients with follicle center-cell lymphoma as demonstrated by laser beam microdissection followed by PCR-analysis of JH gene rearrangement (Fig. 2) .b Within the neoplastic infil trate of centrocytes and centroblasts, a variable number of immunoblasts, small lymphocytes, histiocytes, and in some cases eosinophils and plasma cells can be admixed. The tumor cells express monotypic surface Ig and B cell-associated antigens (CD20, CD79a), reveal CD21 (DRC=dendritic reticulum cells)-positivity and are CD5 negative, whereas variable results are found for CD10 (+/-) and bcl-6 (+/-) depending on the histo pathological pattern. Staining for bcl-2 protein fre quently yields negative results, which is a major differ ence from nodal follicle center-cell lymphoma.
Clonal rearrangement of JH genes can be demon strated in the majority of the cases. The interchrom osomal 14;18 translocation typically observed in nodal follicular lymphomas is usually not found in primary cutaneous follicle center-cell lymphoma. 
Marginal Zone B-cell Lymphoma
Marginal zone B-cell lymphoma has been recognized as a distinct variant of a primary cutaneous B-cell lym phoma.7,8 It is closely related to immunocytoma and MALT-lymphomas. The term SALT (skin-associated lymphoid tissue)-lymphoma has also been used for these tumors.9 Clinically, there are solitary or clustered erythematous patches, papules, nodules, or plaques lo cated on the upper extremities or trunk (Fig. 3) . Gener alized lesions can be observed in a minority of patients. The prognosis is excellent despite frequent recurrences. In a recent study of 62 patients with primary cutaneous marginal zone B-cell lymphoma we found a survival of 98% (Fig. 1B) .
Histology is characterized by dense nodular, diffuse or patchy perivascular/periadnexial infiltrates through out the entire dermis and subcutaneous fat. At scan ning power, a characteristic pattern can be observed: dark areas composed of small lymphocytes (lymphoid nodules) are surrounded by and contrast with pale (Fig. 4) . Neoplastic cells are positive for B cell-associated markers (CD20, CD79a) and display negativity for CD5, CD10 and bcl-6. A typical intra cytoplasmic granular reactivity for the monocytoid B cell-associated antibody KiMlp is frequently found.
Molecular analysis reveals rearrangement of JH genes in about 2/3 of the cases.
Large B-cell Lymphoma of the Leg
Primary cutaneous large B-cell lymphomas are neo plasms of B-lymphocytes consisting predominantly of large cells with features of centroblasts, large centro cytes, and immunoblasts.10-12 Clinically, reddish-brown to bluish-red solitary or grouped tumors and plaques which are located most frequently on the lower legs can be observed (Fig. 5) . Tumors with similar morphologic features can arise also on body areas other than the lower extremities. Ulceration is not uncommon. Older females are frequently affected. The prognosis is more unfavorable than in other types of primary cutaneous B-cell lymphoma, with a 5-year survival rate of ap proximately 60% (Fig. 1C) .
Histology is characterized by dense, diffuse infiltrates of large cells in the entire dermis and subcutis . Cyto morphologically neoplastic cells resemble either immu noblasts or centroblasts. Mitotic figures are frequent . It has been proposed that most cases of primary cutane ous large B-cell lymphoma represent large-cell lym Kerl 
Criteria for the Differential Diagnosis of Cutaneous B-cell Lymphomas from B-cell Pseudolymphomas
Cutaneous pseudolymphomas are inflammatory dis eases that simulate malignant lymphomas either clini cally, histopathologically, or both. They can be divided into T-cell predominant types (examples: chronic actinic dermatitis, lymphomatoid contact dermatitis) and B-cell predominant pseudolymphomas (Table 1) . 13 The differentiation of cutaneous B-cell lymphomas from B-cell pseudolymphomas represents one of the most difficult problems in dermatology. Certain clinical features may be helpful. Pseudolymphomas present themselves often as a single papule or nodule with a smooth surface on a special location (e.g., earlobe), whereas lymphomas tend to be associated with many tumors and can reveal ulceration. Pseudolymphomas occur frequently in children, in contrast to lymphomas.
In pseudolymphomas there may be a history of a caus ative event (e.g., borrelia infection), whereas in lym phomas the cause is usually obscure.
By conventional microscopy, as a rule, infiltrates in pseudolymphomas are less dense and less deep than those of lymphomas. They usually are relatively sym metrical, rather well circumscribed, and more dense in the upper part of the dermis than in the lower part. Often the infiltrates assume a wedge-shaped pattern. In contrast, the infiltrates of lymphomas tend to be more massive, asymmetrical, and poorly circumscribed. Be cause there are many exceptions to each of these "rules" , differentiation between the inflammatory and neoplastic processes of entirely different prognostic po tentiality often is impossible on histopathologic grounds alone.
Immunohistological features14,15 can be studied on routinely fixed, paraffin-embedded biopsy specimens. Malignant cell populations of B-lymphocytes usually show a monoclonal restriction to either x or k light chain, whereas benign infiltrates exhibit a polyclonal pattern with expression of both light chains. Unfortu nately, however, there are several cases of B-cell lym phoproliferative disorders, both benign and malignant, in which the cells do not express immunoglobulins. A useful clue for the diagnosis of follicle center-cell lym phomas with a follicular growth pattern is the dimin ished proliferation activity of malignant germinal cen ters as outlined by the Ki67/MIB-1 antibody. Reactive germinal centers show a high proliferation, whereas malignant ones often are characterized by a much lesser degree of positivity.
About 80% of follicular lymphomas and 15% to 30% of high-grade malignant non-Hodgkin's lymphomas in the lymph nodes are characterized by the t(14;18), which is associated with an overexpression of the bcl-2 oncogene. By contrast, investigation of cutaneous cases showed that the t(14:18) and the bcl-2 protein expres sion is rare in primary cutaneous B-cell lymphomas. Thus, in the skin bcl-2 protein expression cannot be used as a criterion for differentiation of follicle center cell lymphoma from B-pseudolymphoma with follicular pattern.
It has been demonstrated recently, that CD10 and bcl-6 expression, which support a germinal center-cell origin, may be useful in the differential diagnosis of follicle center-cell lymphomas from pseudolymphomas (Fig. 6) . 16 Low-grade malignant lymphomas of B-cell lineage may show aberrant expression of some T-cell-associated markers. CD5 is a pan-T-cell marker that reacts with the cells of most cases of B-cell chronic lymphocytic leukemia. Normal B-lymphocytes are CD43 negative , but several low-grade B-cell lymphomas are CD43 pos itive. The detection of an aberrant phenotype of the B lymphocytes (CD20+, CD5+, CD43+) is considered as a sign of malignancy. High-grade malignant cutaneous B-cell lymphomas often show partial loss of one or more B-cell-associated antigens (CD20).
Concerning the molecular analysis of cutaneous B cell lymphoid proliferations the detection of clonal IgH gene rearrangements using PCR is a very valuable method for assessing clonality. Highly sensitive and specific PCR methods are however required. A helpful technique for the determination of the lineage of neo plastic cells in cutaneous follicle center-cell lymphoma is represented by molecular genetic analysis of single cells isolated by a laser-based microdissection technique. This method allows to isolate a group of cells or single cells for PCR analysis of IgH genes (Fig. 2B) .
Looking towards the future cutaneous lymphomas and pseudolymphomas will soon be defined in relation to their molecular abnormalities" and their etiology or pathogenesis. This information will encourage further progress and the development of better therapies.
